Effectiveness of asoprisnil, a selective progesterone receptor modulator (SPRM) in treating uterine leiomyomata. Advances in Uterine Leiomyoma

Categoria Primary study
GiornaleNIH International Congress
Year 2005
Loading references information
Questo articolo non ha abstract
Epistemonikos ID: e4a79194792bc0fc8ab3b4b228f3402bf87ff99e
First added on: May 12, 2020